We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Horizon Discovery Group Plc | LSE:HZD | London | Ordinary Share | GB00BK8FL363 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 184.50 | 184.50 | 185.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/11/2020 10:11 | So do we sell in the market now or wait till January in the hope of a better offer in the meantime? Or is this fait accompli? | bouleversee | |
02/11/2020 09:59 | OK for recent traders; not much profit for long term holders and losses in some cases for people who did believe in them and have held on but disappointed they are selling out so low. | bouleversee | |
02/11/2020 09:46 | HZD have exceeded expectations as we have great news. MERRY XMAS EVERYONE... especially to those who believed in HZD. IXI is another opportunity with fantastic solutions and products. | halfpenny | |
02/11/2020 09:28 | Wow, that's a whopper of a premium! Well done folks! These bids are starting to pick up a little of late: TALK, MCS, WMH, GFS, AA, KAZ, LID Wonder who is next. | sphere25 | |
02/11/2020 09:20 | I don't understand why they are rushing to accept such a low offer. The share price was 268.50 on 14.8.2017. Poor return for shareholders with no dividends either. I see the share price is slightly above the offer price a.t.m. Does that suggest a higher bid might be forthcoming? | bouleversee | |
02/11/2020 08:40 | Any chance of a counter bid? | wilmot666 | |
02/11/2020 07:30 | WOW WALL OF MONEY Sanofi paying 272% premium for Kiadis today | the stigologist | |
02/11/2020 07:17 | Great news for C4XD ? | the stigologist | |
02/11/2020 07:12 | Goodbye Horizon. That's a fair markup..100% almost It does go to show how the market sometimes prices companies completely wrong only a for a bidder to come along and snap them up at a decent price | mirabeau | |
02/11/2020 07:09 | 185p cash offer | tole | |
24/10/2020 21:03 | Lombard Odier ups its stake from 6.2% to 9.3% (at 90p). Hopefully the determined seller has been taken out. Would be helpful if an rns appears next week so we can see who they are/were. | rambutan2 | |
21/10/2020 16:05 | CRSP had around a $1 Billion wiped off its Market Cap today CRISPR stock slides as CAR-T death overshadows signs of efficacy | the stigologist | |
18/10/2020 09:19 | Video explaining Crispr for AIM investors #HZD #MXCT #C4XD | the stigologist | |
16/10/2020 03:54 | A US listing is in (rather slow) progress. I added a few yesterday at 91p, as I suspect this will appear cheap before too long. | rambutan2 | |
15/10/2020 19:34 | Is it a bit too high tech for UK investors to understand I'm v.high I.Q (like well over 80 probably) and even I don't understand it Maybe best they go to the US where there are more specialist tech funds ? | the stigologist | |
15/10/2020 18:28 | Not replicsted in the share price, however. | bouleversee | |
15/10/2020 17:13 | Went from 4% to 5% last week: | rambutan2 | |
10/10/2020 13:06 | The Times hsd an article the other day saying how well AIM shares hsd done since Covid. Didn't mention Horizon which goes from bsd to worse. Why do you suppose that is? | bouleversee | |
10/10/2020 11:24 | They shouldn't have stalled on the listing earlier in the year... they've missed a trick here given how well US markets have been doing. Does anyone know how long this process takes? | carpingtris | |
30/9/2020 20:01 | Lack of news here... how long does it take to sort that US listing?? Missing out! | carpingtris | |
17/8/2020 16:37 | HZD are now ready to move forward with many Deals in their Pipeline. News flow will come thick and fast and £1.30? will be Sooner than some think. Get ready as HZD can move up very quickly.... | halfpenny | |
17/8/2020 13:21 | When is this one going to turn a profit? Losses galore! Posted here a few times recently because it's a nice one to nip in and out of. There's a decent trading range it keeps bouncing within. No idea on fundamentals here. The outlook is positive and the US listing might mean additional interest but on the whole it's one of those that could go anywhere. Bought a few of these sorts recently: EVG, DDDD and SYM. They've bizarrely all gone higher but still not managed to maximise gains because they're blooming hard work. They go up (making you think they're going to shoot higher) and then come flying back down (making you think they're going to tank alot more) then they do they hokey cokey and end up in some unknown land. Best to book profits as you get them with these sorts. You just can't be sure. Will keep a watch here ahead of the US listing and possibly for some bid rumour if ABC come back with an offer, but it's all very short term based moves. | sphere25 | |
17/8/2020 13:01 | HZD Q3 R&D project driving benefits. HZD Technology driving business customers with UP Front Payments and Royalty. Edit T Cell features changes cell to become a drug. 20/3O million within next 5 years. News update expected this year. Expect return to normality H2. Cash being managed well. EBITDA should improve H2. Staff turnover 15%. IT costs for new website improves services and quality ISO210007 certified this year. Nasdaq listing being worked on. Operating cash flow still positive. Outlook positive and way of working from home working well. Customers relationships improving to a higher level. Outsourcing with sticky services growing H2. Developing screening market and bio production. Drivers remain strong and growing revenue in H2. Q&A Assumption return to growth H2. Driver Academic customers. Customers returning back to work driving demand. RNAI for Covid research online growing. Bio production a challenge and crystal libraries. Outsourcing And Strong Partnership is benefiting HZD. Expecting to outgrow target market overall. Diagnostics and cell line Engineering should grow rapidly and enquiries increasing rapidly. Enjoy HZD price increases for the rest of 2020 and into 2021. My short term Target £1.30 plus plus plus. Future is BRIGHT.. | halfpenny |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions